NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-207-2004-3-US-03 US Plasmids And Phages For Homologous Recombination And Methods Of Use US CON 13/928,237 8859277 Issued PDF
NIAAA E-103-2013-0-US-01 GLUCAN-ENCAPSULATED SIRNA FOR TREATING TYPE 2 DIABETES MELLITUS US 61/839,239 Abandoned
NIDDK E-456-2013-1-US-01 Method of Increasing the Amount of Fetal Hemoglobin in a Cell and/or Mammal US 61/837,840 Abandoned
NIA E-205-2006-2-JP-17 Preparation Of R,R-fenoterol And R,R OR R,S-fenoterol Analogues And Their Use In Treating Congestive Heart Failure JP DIV 2013-129406 Abandoned
NIAID E-120-2013-0-US-01 Cytolethal Distending Toxin Subunit B Conjugated or Fused to Bacillus Anthracis Toxin Lethal Factor US 61/837,428 Abandoned
NHLBI E-026-2013-0-US-01 MRI Scanner Bore Coverings US 61/836,817 Abandoned
NINDS E-088-2012-0-PCT-02 METHODS AND COMPOSITIONS FOR IDENTIFYING JC VIRUS PCT PCT PCT/US2013/046158 Expired
NIAID E-056-2014-0-US-01 Dynamic Viscoelasticity As A Rapid Single-Cell Biomarker US 61/835,971 Abandoned
CC E-227-2012-2-US-01 System, Method And Device For Prostate Diagnosis And Intervention US ORD 13/918,413 9655595 Issued PDF
NCI E-021-2011-0-US-03 Synthetic Peptide Inhibitors Of Wnt Pathway US National Stage 13/917,958 9056891 Abandoned PDF
NCI E-239-2010-0-US-07 Manipulation Of Stem Cell Function By P53 Isoforms US National Stage 13/877,100 Abandoned
NICHD E-348-2013-0-IL-04 BIOMARKER TEST FOR PREDICTION OR EARLY DETECTION OF PREECLAMPSIA AND/OR HELLP SYNDROME IL National Stage 236180 Issued
NICHD E-348-2013-0-CN-07 BIOMARKER TEST FOR PREDICTION OR EARLY DETECTION OF PREECLAMPSIA AND/OR HELLP SYNDROME CN National Stage 201380043605.2 Issued
NIAID E-281-2010-0-US-03 Diagnostic Assays and Methods of Use for Detection of Filarial Infection US National Stage 13/882,850 9068993 Issued PDF
NICHD E-348-2013-0-PCT-03 BIOMARKER TEST FOR PREDICTION OR EARLY DETECTION OF PREECLAMPSIA AND/OR HELLP SYNDROME PCT PCT PCT/US2013/045709 Expired
NCI E-077-2017-0-PCT-02 CATIONIC LIPID VACCINE COMPOSITIONS AND METHODS OF USE PCT PCT PCT/US2013/045578 Expired
NICHD E-348-2013-0-EP-10 BIOMARKER TEST FOR PREDICTION OR EARLY DETECTION OF PREECLAMPSIA AND/OR HELLP SYNDROME EP DIV 16186083.8 Abandoned
NICHD E-348-2013-0-EP-06 BIOMARKER TEST FOR PREDICTION OR EARLY DETECTION OF PREECLAMPSIA AND/OR HELLP SYNDROME EP National Stage 13803743.7 Abandoned
NICHD E-348-2013-0-JP-09 BIOMARKER TEST FOR PREDICTION OR EARLY DETECTION OF PREECLAMPSIA AND/OR HELLP SYNDROME JP National Stage 2015-517433 Abandoned
NICHD E-348-2013-0-IN-08 BIOMARKER TEST FOR PREDICTION OR EARLY DETECTION OF PREECLAMPSIA AND/OR HELLP SYNDROME IN National Stage 201/CHENP/2015 Abandoned
NCI E-215-2007-0-US-11 MicroRNA-181 Family Members Are Involved In The Function Of Liver Cancer Stem Cells Through Beta-catenin Signaling Activation US DIV 13/916,154 Abandoned
NCI E-057-2013-0-US-01 METHOD FOR TREATING TUMORS US 61/834,375 Abandoned
NHLBI E-115-2013-0-US-01 Encircling Suture Delivery System For Flexible Circumferential Suture US 61/834,357 Abandoned
NCI E-351-2013-0-US-01 HER2-SPECIFIC MONOCLONAL ANTIBODIES AND CONJUGATES THEREOF US 61/833,732 Abandoned
NIDDK E-456-2013-0-US-01 Method of Increasing the Amount of Fetal Hemoglobin in a Mammal US 61/833,275 Abandoned
NCATS E-203-2012-0-EP-05 METHODS AND COMPOSITIONS FOR THE INHIBITION OF PIN1 EP National Stage 13800857.8 Issued
NCI E-039-2011-0-US-06 Chimeric Rabbit/Human ROR1 Antibodies US National Stage 13/990,977 9758586 Issued PDF
NCI E-081-2015-1-CA-03 HUMAN BISPECIFIC EGFRVIII ANTIBODY ENGAGING MOLECULES CA National Stage 2876133 Abandoned
NCI E-269-2010-0-US-09 Anti-SSX-2 T Cell Receptors and Related Materials and Methods of Use US National Stage 13/820,802 9345748 Issued PDF
NCI E-081-2015-1-PCT-01 HUMAN BISPECIFIC EGFRVIII ANTIBODY ENGAGING MOLECULES PCT PCT COMB PCT/US2013/044672 Expired
NCI E-081-2015-1-EP-04 HUMAN BISPECIFIC EGFRVIII ANTIBODY ENGAGING MOLECULES EP National Stage 13800038.5 Pending
NCATS E-203-2012-0-PCT-02 METHODS AND COMPOSITIONS FOR THE INHIBITION OF PIN1 PCT PCT PCT/US13/044747 Expired
NCATS E-203-2012-0-AU-03 METHODS AND COMPOSITIONS FOR THE INHIBITION OF PIN1 AU National Stage 2013271378 Abandoned
NCATS E-203-2012-0-CA-04 METHODS AND COMPOSITIONS FOR THE INHIBITION OF PIN1 CA National Stage 2875798 Abandoned
NCATS E-203-2012-0-JP-13 METHODS AND COMPOSITIONS FOR THE INHIBITION OF PIN1 JP DIV 2018-228685 Pending
NCI E-269-2011-0-US-03 KITS FOR DETECTING AND MONITORING ENDOCRINE DISRUPTING CHEMICALS (EDCS) US ORD 13/912,071 9040248 Issued PDF
NCI E-269-2011-0-PCT-02 KITS FOR DETECTING AND MONITORING ENDOCRINE DISRUPTING CHEMICALS (EDCS) PCT PCT PCT/US2013/044569 Expired
NCI E-269-2011-0-EP-04 KITS FOR DETECTING AND MONITORING ENDOCRINE DISRUPTING CHEMICALS (EDCS) EP National Stage 13730754.2 Abandoned
NCI E-315-2007-0-US-04 Method of Inhibiting ABCG2 and Other Treatment Methods US DIV 13/910,238 9314448 Issued PDF
NCI E-292-2007-0-HK-08 DELETIONS IN DOMAIN II OF PSEUDOMONAS EXOTOXIN A THAT REDUCE NON-SPECIFIC TOXICITY HK National Stage 13106628.2 Abandoned
NCI E-034-2013-0-US-01 Monomeric Griffithsin Tandemers US 61/831,336 Abandoned
NICHD E-032-2008-0-US-04 Use Of Saccharides Cross-reactive With Bacillus Anthracis Spore Glycoprotein As A Vaccine Against Anthrax US DIV 13/909,992 8926986 Abandoned PDF
NIAID E-323-2005-3-HK-13 Influenza Hemagglutinin And Neuraminidase Variants HK EP 13106582.6 Abandoned
NIBIB E-314-2013-0-CN-02 Octapod Iron Oxide Nanoparticles As High-Performance T2 Contrast Agents For Magnetic Resonance Imaging CN National Stage 201380077163.3 Issued
NIBIB E-314-2013-0-EP-03 Octapod Iron Oxide Nanoparticles As High-Performance T2 Contrast Agents For Magnetic Resonance Imaging EP National Stage 13886302.2 Issued
NIBIB E-314-2013-0-PCT-01 Octapod Iron Oxide Nanoparticles As High-Performance T2 Contrast Agents For Magnetic Resonance Imaging PCT PCT PCT/CN2013/076645 Expired
NCI E-124-2011-0-US-02 Anti-podoplanin Antibodies And Methods Of Use US National Stage 13/991,308 Abandoned
NCI E-136-2012-0-KR-05 High-Affinity Monoclonal Antibodies To Glypican-3 And Use Thereof KR National Stage 10-2014-7037046 Issued
NCI E-136-2012-0-SG-06 High-Affinity Monoclonal Antibodies To Glypican-3 And Use Thereof SG National Stage 11201407972R Issued
NHLBI E-209-2007-0-US-04 MRI GUIDEWIRE US DIV 13/907,743 9259556 Issued PDF